vTv Therapeutics' Cash Hoard: A Crucial Factor in Growth

vTv Therapeutics has seen its share price rise 139% in the last year despite being a loss-making company. The company has a cash runway of about 4.7 years and has reduced its cash burn by 11% over the past year. While the company's cash burn is a concern, its cash reserves of $99m provide some reassurance. The company's ability to raise more cash and its future prospects will be key to its long-term success.